Skip to content
Disclosery

EXANE DERIVATIVES: LMT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on LMT, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 230 LMT shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 230 shares
    Change vs previous 13F +1 shares

    0.06% of the 13F portfolio, value $98,871.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 229 shares
    Change vs previous 13F -411 shares

    0.03% of the 13F portfolio, value $101,083.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 640 shares
    Change vs previous 13F -227 shares

    0.06% of the 13F portfolio, value $227,473.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 867 shares
    Change vs previous 13F -841 shares

    0.07% of the 13F portfolio, value $299,216.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,708 shares
    Change vs previous 13F -16 shares

    0.15% of the 13F portfolio, value $645,368.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,724 shares
    Change vs previous 13F +1,620 shares

    0.19% of the 13F portfolio, value $637,053.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 104 shares
    Change vs previous 13F -3,903 shares

    0.01% of the 13F portfolio, value $36,920.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 4,007 shares
    Change vs previous 13F not available

    0.5% of the 13F portfolio, value $1,535,844.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).